A comparison of 2024 and 2025 bio/pharma employment survey results indicates that industry professionals face eroding security, polarized satisfaction, and rising attrition risk.
Christopher Cole
Advertisement
Articles by Christopher Cole
Complete this survey to illustrate how new tariffs and trade policy have impacted you and your organization.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
JP Morgan 2026 Wrap Up: Pharma Leaders Speak About the Conference and the State of the Industry
2
Henlius Enters Global Exclusive License Agreement with U-mab Biopharma for Best-in-Class Potential Anti-IL-1RAP mAb
3
GSK Enters $2.2 Billion Definitive Agreement to Acquire RAPT Therapeutics
4
Atkins Announces Partnership with Reality TV Star Heather Gay to Address GLP-1 User’s Mindsets
5